Among the drugs usable against AD, but also in the therapy of myasthenia gravis, cholinesterase inhibitors, compounds also known as anticholinesterase and cholinesterase blockers, play a main role as they prevent the breakdown of the neurotransmitters acetylcholine or butyrylcholine [83]. Here, BCHE is linked to myasthenia gravis.